scispace - formally typeset
D

Don Kulasiri

Researcher at Canterbury of New Zealand

Publications -  137
Citations -  1217

Don Kulasiri is an academic researcher from Canterbury of New Zealand. The author has contributed to research in topics: Stochastic differential equation & Medicine. The author has an hindex of 18, co-authored 126 publications receiving 1050 citations. Previous affiliations of Don Kulasiri include American College of Surgeons & Lincoln University (New Zealand).

Papers
More filters

Validating a gene expression signature of invasive ductal carcinoma of the breast and detecting key genes using neural networks

Don Kulasiri
TL;DR: The validity of differentially expressed genes pertaining to a carefully conducted experiment on breast tissues affected by Invasive Ductal Carcinoma and matched healthy tissues is conducted using neural networks and statistical methods.
Book ChapterDOI

A Generalized Mathematical Model in One-Dimension

TL;DR: There is some promise to characterise the solute dispersion at different flow lengths, and there are some indications that Eq.
Book ChapterDOI

A Large Model Case Study: Solving CME for G1/S Checkpoint Involving the DNA-Damage Signal Transduction Pathway

TL;DR: In this article, the authors investigated the performance of the ''isp LOLAS'' algorithm on a large biochemical system and analyzed the state-space and probabilities of the species by implementing and integrating the mathematical model of the G1/S cell-cycle checkpoint involving the DNA-damage signal transduction pathway.
Proceedings ArticleDOI

Robustness of CDK2 in triggering cellular senescence based on probability of DNA-damaged cells passing G1/S checkpoint

TL;DR: A mathematical model of G1/S transition involving the DNA-damage pathway is implemented and it is shown that cellular senescence can be achieved by lowering CDK2 levels, and a mathematical formulation of robustness indicates that the robustness ofCDK2 -triggeredsenescence increases with decreasing levels of CDK 2, and is slightly greater for low-level DNA damage condition.